KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Assets (2016 - 2025)

Historic Return on Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 0.11%.

  • West Pharmaceutical Services' Return on Assets fell 200.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.12% for FY2025, which is 100.0% down from last year.
  • As of Q4 2025, West Pharmaceutical Services' Return on Assets stood at 0.11%, which was down 200.0% from 0.12% recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Return on Assets peaked at 0.2% during Q1 2022, and registered a low of 0.11% during Q4 2025.
  • For the 5-year period, West Pharmaceutical Services' Return on Assets averaged around 0.15%, with its median value being 0.15% (2021).
  • As far as peak fluctuations go, West Pharmaceutical Services' Return on Assets soared by 800bps in 2021, and later plummeted by -600bps in 2023.
  • Over the past 5 years, West Pharmaceutical Services' Return on Assets (Quarter) stood at 0.2% in 2021, then fell by -18bps to 0.16% in 2022, then fell by -7bps to 0.15% in 2023, then dropped by -14bps to 0.13% in 2024, then dropped by -12bps to 0.11% in 2025.
  • Its Return on Assets was 0.11% in Q4 2025, compared to 0.12% in Q3 2025 and 0.13% in Q2 2025.